117 related articles for article (PubMed ID: 3167866)
1. Modulation of the cytotoxic effect of 5-fluorouracil by N-methylformamide on a human colon carcinoma cell line.
Zupi G; Marangolo M; Arancia G; Greco C; Laudonio N; Iosi F; Formisano G; Malorni W
Cancer Res; 1988 Nov; 48(21):6193-200. PubMed ID: 3167866
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel and N-methylformamide: in vitro interactions in human colon cancer cell line.
Valenti AM; Niero A; Monti G; Marangolo F; Marangolo M
Anticancer Res; 1997; 17(4A):2491-7. PubMed ID: 9252669
[TBL] [Abstract][Full Text] [Related]
3. Different effects of sequential combinations of N-methylformamide with 5-fluorouracil on human colon carcinoma cells growing in nude mice.
Arancia G; Leonetti C; Malorni W; Greco C; Formisano G; Marangolo M; Zupi G
J Cancer Res Clin Oncol; 1991; 117(4):351-8. PubMed ID: 2066356
[TBL] [Abstract][Full Text] [Related]
4. Role of glutathione depletion in the mechanism of action of N-methylformamide and N,N-dimethylformamide in a cultured human colon carcinoma cell line.
Cordeiro RF; Savarese TM
Cancer Res; 1986 Mar; 46(3):1297-305. PubMed ID: 3943098
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the effects of the hyperthermic treatment by N-methylformamide on a human melanoma cell line.
Arancia G; Meschini S; Matarrese P; Malorni W; Candiloro A; Mattioni M; Santoni G; Zupi G
Anticancer Res; 1994; 14(3A):905-13. PubMed ID: 8074492
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of radiation-induced DNA double-strand breaks and micronuclei in human colon carcinoma cells by N-methylformamide.
Tofilon PJ; Vines CM; Bill CA
Radiat Res; 1989 Jul; 119(1):166-75. PubMed ID: 2756107
[TBL] [Abstract][Full Text] [Related]
7. Induction of doxorubicin resistance in heterogeneous human colon tumor cells by N-methylformamide.
Ferrari LA; Bliven SF; Wiemann M; Calabresi P; Glicksman AS; Leith JT
Cancer Treat Rep; 1986 Oct; 70(10):1177-80. PubMed ID: 3756940
[TBL] [Abstract][Full Text] [Related]
8. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
[TBL] [Abstract][Full Text] [Related]
9. Combination of N-methylformamide with cis-diamminedichloroplatinum (II) in murine mammary carcinoma: importance of timing.
Iwakawa M; Tofilon PJ; Arundel C; Milas L
Cancer Res; 1989 Apr; 49(7):1640-3. PubMed ID: 2924311
[TBL] [Abstract][Full Text] [Related]
10. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells.
De Filippi R; Prete SP; Giuliani A; Silvi E; Yamaue H; Nieroda CA; Greiner JW; De Vecchis L; Bonmassar E
Anticancer Res; 1994; 14(5A):1767-73. PubMed ID: 7847809
[TBL] [Abstract][Full Text] [Related]
12. Enhancement by N-methylformamide of the effect of ionizing radiation on a human colon tumor xenografted in nude mice.
Dexter DL; Lee ES; Bliven SF; Glicksman AS; Leith JT
Cancer Res; 1984 Nov; 44(11):4942-6. PubMed ID: 6488157
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of 5-fluorouracil and carboplatin against human gastric cancer cell lines in vitro and in vivo.
Saikawa Y; Kubota T; Kuo TH; Tanino H; Kase S; Furukawa T; Watanabe M; Ishibiki K; Kitajima M; Hoffman RM
Anticancer Res; 1994; 14(2A):461-4. PubMed ID: 8017848
[TBL] [Abstract][Full Text] [Related]
14. Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line.
Laudonio N; Zupi G; Erba E; Leonetti C; D'Incalci M
Br J Cancer; 1990 Mar; 61(3):377-81. PubMed ID: 2328201
[TBL] [Abstract][Full Text] [Related]
15. Enhanced X ray sensitivity of human colon tumor cells by combination of N-methylformamide with chemotherapeutic agents.
Leith JT; Lee ES; Leite DV; Glicksman AS
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1423-7. PubMed ID: 2428792
[TBL] [Abstract][Full Text] [Related]
16. Importance of cell cycle perturbations on the effectiveness of N-methylformamide and anti-neoplastic drugs in combination.
Cucco C; D'Agnano I; Marangolo M; Candiloro A; Zupi G
Cell Prolif; 1991 May; 24(3):293-303. PubMed ID: 2039805
[TBL] [Abstract][Full Text] [Related]
17. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
18. Effects of sequential combinations of N-methylformamide with adriamycin on cultured melanoma cells (M14).
Arancia G; Molinari A; Calcabrini A; Citro G; Villa AM; Verdina A; Zupi G
Exp Mol Pathol; 1994 Feb; 60(1):12-26. PubMed ID: 8162967
[TBL] [Abstract][Full Text] [Related]
19. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways.
Hwang JT; Ha J; Park OJ
Biochem Biophys Res Commun; 2005 Jul; 332(2):433-40. PubMed ID: 15896711
[TBL] [Abstract][Full Text] [Related]
20. Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data.
Fischel JL; Etienne MC; Formento P; Milano G
Clin Cancer Res; 1998 Oct; 4(10):2529-35. PubMed ID: 9796987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
